In conclusion, our study suggests that inhibition of VEGF by intravitreal bevacizumab injection results in significant improvement in BCVA and reduction in central macular thickness to produce a clinically meaningful and statistically significant benefit in patients with
diabetic macular edema, who had already received macular laser photocoagulation; this beneficial effect was shown to persist for up to three months.
Diabetic retinopathy, including
diabetic macular edema is the leading cause of visual impairment and blindness in the working age population and represents a large and growing medical need that is not adequately addressed by current treatment approaches.
Bevacizumab for the management of
diabetic macular edema.
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for
diabetic macular edema.
Diabetic macular edema is a significant public health challenge.
Optical coherence tomography assessment of the vitreoretinal relationship in
diabetic macular edema.
The report reviews key players involved in the therapeutics development for
Diabetic Macular Edema and enlists all their major and minor projects
For the first time, Americans with
diabetic macular edema will have access to an FDA-approved medicine shown to help many patients rapidly regain substantial amounts of lost vision," said Dr.
The Food and Drug Administration has approved ranibizumab for treatment of
diabetic macular edema.
as a treatment for the condition known as
diabetic macular edema.
A promising new drug therapy used to treat abnormal swelling in the eye -- a condition called
diabetic macular edema -- proved less effective than traditional laser treatments in a study funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH).
Recently I was evaluated by VA medical center staff, who informed me I have
diabetic macular edema, with retinopathy associated with my diabetes mellitus type II.
